Literature DB >> 27966489

Reserpine requires the D2-type receptor, dop-3, and the exoribonuclease, eri-1, to extend the lifespan in C. elegans.

Kopal Saharia1, Ranjeet Kumar, Kuldeep Gupta, Shrilekha Mishra, Jamuna R Subramaniam.   

Abstract

Lifespan extension is an all systems encompassing event. Involvement of reduced insulin/IGF1 signalling is well worked out, first in the model organism Caenorhbaditis elegans followed by other systems including humans. But the role of neuronal component in lifespan extension is not well understood due to the refractory nature of neurons to small RNA interference (sRNAi) in C. elegans. Earlier, we have demonstrated that an antihypertensive drug, reserpine, extends lifespan through modulation of neurotransmitter release, especially, acetylcholine, in C. elegans. Intriguingly, the reserpine mediated lifespan extension (RMLE) does not happen through the known longevity pathways. Here, we report that the D2-type dopamine receptor (DOP-3), which acts through the inhibitory Gprotein coupled (G alpha i) pathway mediated signalling is partly required for RMLE. In the dop-3 loss of function mutant RMLE is shortened. DOP-3 acts through Gαo (goa-1). One of the downstream targets of G protein signalling is the transcription factor, jun-1. MRP-1, an ATP binding cassette transporter, belonging to the multidrug resistance protein family is one of the genes turned on by JUN-1. RMLE is shortened in dop-3-->goa-1-->jun1-->mrp-1 loss of function mutants, elucidating the contribution of dop-3 signalling. The dop-3 receptor system is known to inhibit acetylcholine release. This suggests dopamine receptor, dop-3 could be contributing to the modulation of acetylcholine release by reserpine. ERI-1 is a 3'-5' exoribonuclease, one of the negative regulators of sRNAi, whose loss of function makes neurons amenable to siRNA. In the absence of eri-1, RMLE is shortened. In the dop-3 loss-of-function background, lack of eri-1 completely abolishes RMLE. This suggests that dop-3 and eri-1 act in independent parallel pathways for RMLE and these two pathways are essential and sufficient for the longevity enhancement by reserpine in C. elegans.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27966489     DOI: 10.1007/s12038-016-9652-7

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  24 in total

1.  Coexpressed D1- and D2-like dopamine receptors antagonistically modulate acetylcholine release in Caenorhabditis elegans.

Authors:  Andrew T Allen; Kathryn N Maher; Khursheed A Wani; Katherine E Betts; Daniel L Chase
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

2.  Dopaminergic neurons in the nematode Caenorhabditis elegans.

Authors:  J Sulston; M Dew; S Brenner
Journal:  J Comp Neurol       Date:  1975-09-15       Impact factor: 3.215

3.  Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation.

Authors:  L D Cripe; V M Gelfanov; E A Smith; D R Spigel; C A Phillips; T G Gabig; S-H Jung; J Fyffe; A D Hartman; P Kneebone; D Mercola; G S Burgess; H S Boswell
Journal:  Leukemia       Date:  2002-05       Impact factor: 11.528

4.  Characterization of GAR-2, a novel G protein-linked acetylcholine receptor from Caenorhabditis elegans.

Authors:  Y S Lee; Y S Park; S Nam; S J Suh; J Lee; B K Kaang; N J Cho
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

5.  Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans.

Authors:  Daniel L Chase; Judy S Pepper; Michael R Koelle
Journal:  Nat Neurosci       Date:  2004-09-19       Impact factor: 24.884

6.  The exonuclease ERI-1 has a conserved dual role in 5.8S rRNA processing and RNAi.

Authors:  Harrison W Gabel; Gary Ruvkun
Journal:  Nat Struct Mol Biol       Date:  2008-04-27       Impact factor: 15.369

7.  Mouse Eri1 interacts with the ribosome and catalyzes 5.8S rRNA processing.

Authors:  K Mark Ansel; William A Pastor; Nicola Rath; Ariya D Lapan; Elke Glasmacher; Christine Wolf; Laura C Smith; Nikoletta Papadopoulou; Edward D Lamperti; Mamta Tahiliani; Joachim W Ellwart; Yujiang Shi; Elisabeth Kremmer; Anjana Rao; Vigo Heissmeyer
Journal:  Nat Struct Mol Biol       Date:  2008-04-27       Impact factor: 15.369

8.  The genetics of Caenorhabditis elegans.

Authors:  S Brenner
Journal:  Genetics       Date:  1974-05       Impact factor: 4.562

9.  Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan.

Authors:  Nataliya Libina; Jennifer R Berman; Cynthia Kenyon
Journal:  Cell       Date:  2003-11-14       Impact factor: 41.582

10.  A Drosophila ABC transporter regulates lifespan.

Authors:  He Huang; Ying Lu-Bo; Gabriel G Haddad
Journal:  PLoS Genet       Date:  2014-12-04       Impact factor: 5.917

View more
  3 in total

1.  Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone.

Authors:  Osama Refai; Randy D Blakely
Journal:  Neurochem Int       Date:  2018-05-22       Impact factor: 3.921

2.  Serotonin and dopamine modulate aging in response to food odor and availability.

Authors:  Hillary A Miller; Shijiao Huang; Elizabeth S Dean; Megan L Schaller; Angela M Tuckowski; Allyson S Munneke; Safa Beydoun; Scott D Pletcher; Scott F Leiser
Journal:  Nat Commun       Date:  2022-06-07       Impact factor: 17.694

Review 3.  G protein-coupled receptors that influence lifespan of human and animal models.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Biogerontology       Date:  2021-12-03       Impact factor: 4.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.